The National Medical Products Administration approves and agrees to the Fujian and Henan Provincial Drug Administrations to carry out pilot reforms on optimizing the review and approval procedures for supplementary applications of pharmaceuticals.

2026-03-25 07:05:37

People’s Financial News, March 24 — The National Medical Products Administration announced approval, allowing the drug administrations of Fujian and Henan provinces to carry out pilot reforms to optimize the review and approval process for supplemental drug applications.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.